European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the Europea…

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver therapies to ...
Le Lézard

European Commission Approves BRINSUPRItm (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced ...
TipRanks on MSN

Insmed’s Brinsupri approved in EU for non-cystic fibrosis bronchiectasis

Incorporated announced that the European Commission has approved BRINSUPR for the treatment of non-cystic fibrosis bronchiectasis in ...

Older Brits with these health issues could be due extra £458 a month in 2026

The Department for Work and Pensions (DWP) is set to increase certain payments by 3.8 per cent from April next year ...

Extra £458 a month could be due to pensioners with these health issues next year

The Department for Work and Pensions (DWP) is set to increase certain payments by 3.8 per cent from April next year ...

Pensioners with these health issues could be due up to £458 each month from April

These benefits, which are not means-tested, are worth either £73.90 for the lower rate or £110.40 for the higher rate each ...